Oral Versus Intravenous Fluoropyrimidines for Advanced Colorectal Cancer: By Either Route, It’s All the Same

This publication has 11 references indexed in Scilit:

• Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
  Journal of Clinical Oncology, 2001
• Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
  Journal of Clinical Oncology, 2001
• Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.
  Journal of Clinical Oncology, 1998
• Uracil-ftorafur: an oral fluoropyrimidine active in colorectal cancer.
  Journal of Clinical Oncology, 1998
• Oral fluoropyrimidines in the treatment of colorectal cancer
  European Journal Of Cancer, 1998
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
  Published by Elsevier ,1998
• Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.
  Journal of Clinical Oncology, 1998
• Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase.
  Journal of Clinical Oncology, 1996
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma
  Cancer, 1975